...
首页> 外文期刊>BMC Family Practice >Collaborative care for anxiety disorders in primary care: a systematic review and meta-analysis
【24h】

Collaborative care for anxiety disorders in primary care: a systematic review and meta-analysis

机译:初级保健中焦虑症的协作治疗:系统评价和荟萃分析

获取原文
           

摘要

Background Studies evaluating collaborative care for anxiety disorders are recently emerging. A systematic review and meta-analysis to estimate the effect of collaborative care for adult patients with anxiety disorders in primary care is therefore warranted. Methods A literature search was performed. Data sources: PubMed, Psycinfo, Embase, Cinahl, and the Cochrane library. Study eligibility criteria: Randomized controlled trials examining the effects of collaborative care for adult primary care patients with an anxiety disorder, compared to care as usual or another intervention. Synthesis methods: Standardized mean differences (SMD) on an anxiety scale closest to twelve months follow-up were calculated and pooled in a random effects meta-analysis. Results Of the 3073 studies found, seven studies were included with a total of 2105 participants. Included studies were of moderate to high quality. Collaborative care was superior to care as usual, with a small effect size (SMD?=?0.35 95?% CI 0.14–0.56) for all anxiety disorders combined and a moderate effect size (SMD?=?0.59, 95?% CI 0.41–0.78) in a subgroup analysis (five studies) on patients with panic disorder. Conclusions Collaborative care seems to be a promising strategy for improving primary care for anxiety disorders, in particular panic disorder. However, the number of studies is still small and further research is needed to evaluate the effectiveness in other anxiety disorders.
机译:评估针对焦虑症的协作治疗的背景研究最近正在兴起。因此,有必要进行系统的回顾和荟萃分析,以评估协作治疗对成人焦虑症成年患者在初级保健中的作用。方法进行文献检索。数据来源:PubMed,Psycinfo,Embase,Cinahl和Cochrane库。研究资格标准:与往常照护或其他干预相比,随机对照试验研究了协作治疗对成人焦虑症成年初级护理患者的影响。合成方法:计算最接近十二个月随访的焦虑量表的标准平均差异(SMD),并汇总在随机效应荟萃分析中。结果在发现的3073项研究中,纳入了7项研究,共有2105名参与者。纳入的研究为中等至高质量。协作治疗优于常规照护,对所有焦虑症的合并效应均较小(SMD≥0.3595%CI 0.14–0.56),中等效应仅占SMD≥0.59,95%CI 0.41 –0.78)在恐慌症患者的亚组分析(五项研究)中。结论协作治疗似乎是改善焦虑症(特别是惊恐症)初级保健的一种有前途的策略。然而,研究的数量仍然很少,需要进一步的研究来评估在其他焦虑症中的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号